Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Lantheus Holdings, Inc. LNTH NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
83/100
7/7 Pass
SharesGrow Intrinsic Value
$158.94
+92.1%
Analyst Price Target
$87.00
+5.1%

Lantheus Holdings, Inc. (LNTH) has 12 identified peers for comparison in the Healthcare sector. Peers include ALKS, ALVOW, AMPH, ANIP, AQST, AVDL and others.

LNTH has a market capitalization of $5.39B, compared to an average peer market cap of $2.37B. LNTH is significantly larger than its average peer.

People Also View

NBIX
NBIX
Neurocrine Biosciences, Inc.
$130.81
+3.55%
 CTLT
CTLT
Catalent, Inc.
$63.48
+0.00%
 RDY
RDY
Dr. Reddy's Laboratories Limited
$13.13
-1.06%
 ALKS
ALKS
Alkermes plc
$33.87
+0.36%
 DCPH
DCPH
Deciphera Pharmaceuticals, Inc.
$25.59
+0.08%
 AVDL
AVDL
Avadel Pharmaceuticals plc
$21.64
+0.00%
 DVAX
DVAX
Dynavax Technologies Corporation
$15.50
+0.00%
 ANIP
ANIP
ANI Pharmaceuticals, Inc.
$78.29
-0.03%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message